We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AbbVie to Seek Approval for Potential Blockbuster Leukemia Treatment
AbbVie to Seek Approval for Potential Blockbuster Leukemia Treatment
AbbVie said it will seek FDA approval later this year for its investigational leukemia treatment venetoclax, after the drug met its primary goal in a Phase 2 trial.